Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence

Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence

Background Cannabis-based medicinal products (CBMPs) are increasingly being used to treat post-traumatic stress disorder (PTSD), despite limited evidence of their efficacy. PTSD is often comorbid with major depression, and little is known about whether comorbid depression alters the effectiveness o...

Full description

Bibliographic Details
Main Authors: Michael T. Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Katrin Schlag, David J. Nutt
Format: Article
Language:English
Published: Cambridge University Press 2024-03-01
Series:BJPsych Open
Subjects:
Post-traumatic stress disorder
comorbidity
depressive disorders
medicinal cannabis
treatment outcome
Online Access:https://www.cambridge.org/core/product/identifier/S2056472424000139/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S2056472424000139/type/journal_article

Similar Items